Increased plasma osteoprotegerin concentrations are associated with indices of bone strength of the hip.
about
Antagonistic pleiotropy as a widespread mechanism for the maintenance of polymorphic disease allelesSerum osteoprotegerin levels are related to height loss: the Tromsø Study.Hip structural parameters over 96 weeks in HIV-infected adults switching treatment to tenofovir-emtricitabine or abacavir-lamivudineInfluence of polymorphisms in the RANKL/RANK/OPG signaling pathway on volumetric bone mineral density and bone geometry at the forearm in men.Cystatin C as a potential predictor of osteoprotegerin levels in healthy men, a cross-sectional, observational study.Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort.Relationship between Serum Levels of OPG and TGF- β with Decreasing Rate of BMD in Native Chinese Women.Bivariate genome-wide linkage analysis of femoral bone traits and leg lean mass: Framingham studyIncreased bone resorption is associated with increased risk of cardiovascular events in men: the MINOS study.Prediction of Fractures and Major Cardiovascular Events in Men Using Serum Osteoprotegerin Levels: The Prospective STRAMBO Study.Effect of r-Mt-Cpn10 on human osteoblast cells.Mycobacterium tuberculosis 10-kDa co-chaperonin regulates the expression levels of receptor activator of nuclear factor-κB ligand and osteoprotegerin in human osteoblastsCirculating levels of dickkopf-1, osteoprotegerin and sclerostin are higher in old compared with young men and women and positively associated with whole-body bone mineral density in older adults.
P2860
Q21261495-86C99C7A-FF96-4ACE-848E-5C429328A9E9Q34940502-5E0A506E-EAA4-4D8F-AA53-6E4DCFB4A7C7Q35145668-4D5120BE-2393-4145-9DDF-230847C62087Q35549417-24AB153E-2E16-438D-B7B5-B8C17CC8CF3FQ35756761-E3BECDA2-22D3-4124-B16C-1D46585D5B31Q36273402-E89501C5-69F8-416E-8C74-7628E4914BF2Q36634504-FD20ADB4-F508-41C2-85FC-E06F92EBCF89Q37137458-4468863D-1F1B-4307-81EE-3840D6F91A52Q37469378-7307E328-3EEB-4CED-AF8B-951415FCF3FDQ38693577-DBED3B4B-2352-4CE2-A640-382C765AB739Q42016102-4436BB6A-045E-457F-8C54-B9C17149B89AQ42174421-3F464BC0-E301-4C83-BDD1-093947176D6AQ47740614-4DFA5567-C7A7-47BB-AF13-EB675F39B3F4
P2860
Increased plasma osteoprotegerin concentrations are associated with indices of bone strength of the hip.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Increased plasma osteoproteger ...... s of bone strength of the hip.
@ast
Increased plasma osteoproteger ...... s of bone strength of the hip.
@en
type
label
Increased plasma osteoproteger ...... s of bone strength of the hip.
@ast
Increased plasma osteoproteger ...... s of bone strength of the hip.
@en
prefLabel
Increased plasma osteoproteger ...... s of bone strength of the hip.
@ast
Increased plasma osteoproteger ...... s of bone strength of the hip.
@en
P2093
P2860
P50
P356
P1476
Increased plasma osteoproteger ...... es of bone strength of the hip
@en
P2093
Kerry E Broe
Sekar Kathiresan
Thomas J Beck
P2860
P304
P356
10.1210/JC.2007-2492
P407
P577
2008-02-26T00:00:00Z